Citalopram-induced Raynaud's phenomenon.
Peiró
A M
AM
Clinical Pharmacology Unit, Hospital General de Alicante, c/Pintor Baeza s/n, 03010, Alicante, Spain. peiro_ana@gva.es
Margarit
C
C
Torra
M
M
D000328:Adult; D000700:Analgesics / Q000627:therapeutic use; D015283:Citalopram / Q000009:adverse effects*; D003866:Depressive Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009437:Neuralgia / Q000188:drug therapy / Q000523:psychology*; D011928:Raynaud Disease / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*
D000700:Analgesics; D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors